Market Overview

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)

123.76 -0.47 (-0.38%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/25/19BMO CapitalMaintainsOutperform143.0
11/21/19BMO CapitalMaintainsOutperform138.0
11/21/19Morgan StanleyMaintainsOverweight141.0
11/21/19Cantor FitzgeraldMaintainsOverweight159.0
11/21/19BarclaysMaintainsOverweight131.0
11/20/19OppenheimerInitiates Coverage OnOutperform128.0
11/13/19Bank of AmericaInitiates Coverage OnBuy110.0
9/04/19UBSMaintainsNeutral96.0
9/03/19Piper JaffrayMaintainsOverweight145.0
8/07/19Morgan StanleyMaintainsOverweight124.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter